U.S. Beverage Stock News

In early March 2026, Genevant Sciences and Arbutus Biopharma reached a global settlement with Moderna over alleged unauthorized use of LNP delivery technology in its COVID-19 vaccines, with Moderna agreeing to pay US$950 million upfront in July 2026 and up to an additional US$1.30 billion depending on a future appellate ruling, while also receiving a global non-exclusive license for infectious disease applications. Around the same time, Moderna reported completion of a key Phase 1...

Jack Henry & Associates (JKHY) is back in focus after its Financial Crimes Defender platform was added to the Independent Community Bankers of America Preferred Service Provider program, highlighting its role in fraud prevention for community banks. See our latest analysis for Jack Henry & Associates. At a latest share price of $168.77, Jack Henry & Associates has seen a 7.71% 1 month share price return but a 10.06% 3 month share price decline. Its 5 year total shareholder return of 21.27%...

Interest in Polaris (PII) has picked up after its addition to the Russell 1000 ETF, along with plans to sell its Indian motorcycle brand to Carolwood and fresh coverage from Wells Fargo. See our latest analysis for Polaris. Despite the latest headlines, momentum in Polaris stock has cooled, with a 30-day share price return of 23.38% and a year to date share price return of 24.14%, even as the 1-year total shareholder return stands at 25.31%. Recent attention around its Russell 1000 inclusion,...

In recent days, Sunrun reported softer expectations for near-term earnings as analysts cut forecasts and voiced concern about slower solar origination and capacity deployment, even while revenue is still expected to grow. At the same time, Sunrun remains a major force in U.S. residential battery storage, controlling roughly half of 2025 installations and about 44% of national residential storage capacity, highlighting a tension between operational leadership and financial strain. Now we’ll...

Dianthus Therapeutics recently reported an early GO decision in its Phase 3 CAPTIVATE trial of claseprubart for CIDP, after achieving 20 confirmed responders ahead of the planned interim analysis and confirming a favorable safety profile through independent DSMB review. On the heels of these clinical results, the company completed a large follow-on public equity offering of common stock and pre-funded warrants, raising roughly US$719,000,000 to support ongoing trials, commercial readiness,...

What Recent Returns Say About BorgWarner BorgWarner (BWA) has drawn investor attention after a mixed run in its share price, with a recent month decline contrasting with gains over the past 3 months, year to date, and the past year. That backdrop, alongside annual revenue of about US$14.3b and net income of US$277 million, sets the stage for a closer look at how the auto technology supplier’s current valuation compares with its recent performance. See our latest analysis for BorgWarner. At...

In March 2026, Agios Pharmaceuticals announced that the Emirates Drug Establishment approved PYRUKYND (mitapivat) as the only authorized treatment in the UAE for adult patients with both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, expanding its reach in the Gulf region via its NewBridge Pharmaceuticals partnership. This approval deepens Agios’s footprint in rare hematologic diseases across the Gulf Cooperation Council, reinforcing the importance of...

Event context and recent share performance Sonic Automotive (SAH) has drawn investor attention after a period of mixed share performance, with the stock down about 1% over the past week and roughly 9% over the past 3 months. See our latest analysis for Sonic Automotive. At a share price of $59.89, Sonic Automotive’s recent 1 day and 90 day share price declines of 1.32% and 8.8% contrast with a 1 year total shareholder return of 4.01%. This suggests that short term momentum has cooled while...

Cboe Global Markets, Inc. has announced plans to launch the Cboe IBIT Volatility Index and a new prediction markets framework, extending its VIX methodology into bitcoin and introducing three-outcome, fixed-return contracts initially tied to Mini S&P 500 Index prediction markets. By pairing a bitcoin volatility gauge with an options-style prediction market that allows partial payouts, Cboe is seeking to broaden access to outcome-based trading while aligning it with established exchange...

Trevi Therapeutics (TRVI) has secured FDA alignment on its clinical plan for nalbuphine ER in IPF related chronic cough, clearing the way for two randomized, double blind, placebo controlled Phase 3 trials starting later this year. See our latest analysis for Trevi Therapeutics. That FDA alignment comes after a recent pullback, with a 7 day share price return showing a decline of 17.22% and a 90 day share price return showing a decline of 12.69%. However, the 1 year total shareholder return...

Xcel Energy (XEL) has drawn fresh attention after issuing US$800,000,000 of 5.75% junior subordinated notes due 2056, a long dated financing move that sits alongside reaffirmed earnings guidance and a large investment pipeline. See our latest analysis for Xcel Energy. At a share price of US$81.91, Xcel Energy has a 90 day share price return of 8.17% and a year to date share price return of 9.68%. Its 1 year total shareholder return of 21.15% and 5 year total shareholder return of 52.37%...

NGL Energy Partners (NGL) has drawn fresh investor attention after closing a seven year US$950 million senior secured term loan and amending its asset based revolving credit facility to reshape its capital structure. See our latest analysis for NGL Energy Partners. These financing moves come after a strong run for investors, with the 1 year total shareholder return at about 140%. At the same time, the recent 1 month share price return of a 6.67% decline suggests some cooling in short term...

What recent returns suggest about Chemed’s profile Chemed (CHE) has drawn attention after a month return of about 15% decline and a past 3 months return of about 7% decline, raising questions about how its current valuation lines up with its fundamentals. See our latest analysis for Chemed. At a share price of US$401.87, Chemed’s recent 30-day share price return of about a 15% decline and 1-year total shareholder return of about a 32% decline point to fading momentum after a weaker period for...

On March 9, 2026, Viper Energy withdrew a prior shelf registration for debt securities and filed a new omnibus shelf covering Class A common stock, preferred stock, warrants, and debt. This refreshed universal shelf registration increases the company’s flexibility to raise different types of capital, which may support its dividend-focused, royalty-based business model over time. We’ll now examine how this expanded capital-raising flexibility could influence Viper Energy’s existing investment...

Aeva Technologies recently presented at the Morgan Stanley Technology, Media & Telecom Conference and the 2nd Annual CG Virtual Sustainability Summit, and has since marked its fifth anniversary as a public company by ringing the Nasdaq Closing Bell. Together with expanding its next-generation perception platform into factory automation, smart infrastructure and defense, Aeva has also delivered five consecutive quarters of rising net sales, indicating building operational momentum despite...

Quarterly results put H&R Block’s AI model in focus H&R Block (HRB) is back in the spotlight after recent quarterly results highlighted revenue growth tied to a 15.6% rise in assisted tax preparation and a 22.3% gain in do it yourself software usage. For investors, the company’s combination of human expertise and AI tools, which has reportedly outperformed more AI native competitors, raises questions about how this model might support H&R Block’s business mix and long term positioning. See...

Enpro (NPO) has drawn attention after its recent share moves, with the stock down about 12% over the past month but still showing a positive total return over the past 3 months. See our latest analysis for Enpro. That recent 11.7% 30 day share price decline, alongside a softer 7 day move, sits against a 10.4% 90 day share price return and a 1 year total shareholder return of 37.8%. This suggests momentum has cooled after a strong run. If Enpro’s move has you thinking about where growth and...

TechnipFMC recently saw heavy trading on Euronext alongside analyst upgrades, increased positions from major institutional investors, a small quarterly dividend declaration, and confirmation that CEO Doug Pferdehirt spoke at the Piper Sandler Energy Conference in Las Vegas. This combination of stronger institutional participation and a widely watched technical setup has drawn short-term traders and longer-term investors to reassess the company’s position in offshore energy services. With...

Event context and recent performance snapshot WSFS Financial (WSFS) has drawn fresh attention after recent trading, with the stock showing a 0.3% daily decline and a small 0.4% slip over the past week, putting its recent moves back in focus for investors. Over the past month the share price shows a 6.1% decline. Total return over the past 3 months, year to date, 1 year, 3 years and 5 years is 8.0%, 13.9%, 22.1%, 68.9% and 28.5% respectively. This offers a broad view of how the name has...

On 3 March 2026, Neudata announced a partnership with State Street to expand State Street's Data Intelligence capability, offering institutional investors macroeconomic and market indicators powered by alternative datasets and showcased through Neudata's 2026 global data summits. This collaboration positions State Street to more deeply embed its institutional-grade data insights into real-world investment workflows, highlighting the growing importance of alternative data in macro and private...

In recent months, Atmos Energy has outlined plans to invest US$3.60 billion in fiscal 2025 and US$4.20 billion in fiscal 2026 to upgrade and expand its natural gas transmission and distribution network, supported by a backdrop of lower interest rates that help make these large projects more affordable. This combination of heavier infrastructure spending and a more supportive financing climate highlights how Atmos Energy is positioning its regulated network to capture growing natural gas...

Insider buying and earnings beat put MGE Energy (MGEE) back on investor radar Recent insider buying by director James G. Berbee, a fourth quarter revenue beat, continued dividend growth, and a fresh sector update from Morgan Stanley have drawn new attention to MGE Energy (MGEE). See our latest analysis for MGE Energy. Even with insider buying and upbeat earnings, the recent 7 day share price return of 6.36% and 30 day share price return of 9.79% show pressure on the stock. The 1 year total...

Tyson Foods stock after recent performance Tyson Foods (TSN) has seen mixed share performance recently, with a 1-day return of about a 1.2% decline and a 7-day return near a 1.8% decline, while the past 3 months sit slightly positive. See our latest analysis for Tyson Foods. With the share price at about $60.32, Tyson Foods has pulled back over the past month, while its year to date share price return and 1 year total shareholder return both sit modestly positive. This suggests momentum has...

If you are looking at NIKE and wondering whether the recent share price reflects its true worth, you are not alone. This article is built to help you frame that question clearly. The stock closed at US$53.98, with returns of a 5.3% decline over 7 days, 14.5% decline over 30 days, 14.7% decline year to date, 22.8% decline over 1 year, 52.5% decline over 3 years and 57.6% decline over 5 years. These figures may change how investors think about both risk and potential opportunity. Recent...